Correlation Between TG Therapeutics and Freegold Ventures

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Freegold Ventures at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Freegold Ventures into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Freegold Ventures Limited, you can compare the effects of market volatilities on TG Therapeutics and Freegold Ventures and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Freegold Ventures. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Freegold Ventures.

Diversification Opportunities for TG Therapeutics and Freegold Ventures

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between TGTX and Freegold is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Freegold Ventures Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Freegold Ventures and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Freegold Ventures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Freegold Ventures has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Freegold Ventures go up and down completely randomly.

Pair Corralation between TG Therapeutics and Freegold Ventures

Given the investment horizon of 90 days TG Therapeutics is expected to generate 1.11 times more return on investment than Freegold Ventures. However, TG Therapeutics is 1.11 times more volatile than Freegold Ventures Limited. It trades about 0.14 of its potential returns per unit of risk. Freegold Ventures Limited is currently generating about -0.23 per unit of risk. If you would invest  2,339  in TG Therapeutics on September 30, 2024 and sell it today you would earn a total of  914.00  from holding TG Therapeutics or generate 39.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

TG Therapeutics  vs.  Freegold Ventures Limited

 Performance 
       Timeline  
TG Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Freegold Ventures 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Freegold Ventures Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

TG Therapeutics and Freegold Ventures Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TG Therapeutics and Freegold Ventures

The main advantage of trading using opposite TG Therapeutics and Freegold Ventures positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Freegold Ventures can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Freegold Ventures will offset losses from the drop in Freegold Ventures' long position.
The idea behind TG Therapeutics and Freegold Ventures Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stocks Directory
Find actively traded stocks across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios